These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1708430

  • 1. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
    Uemura Y, Niiya K, Takeuchi T, Miyoshi I.
    Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
    [Abstract] [Full Text] [Related]

  • 2. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T, Niiya K, Sakuragawa N, Ichihara K, Yamazaki T, Watanabe A.
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunoblotting analysis of acquired factor VIII inhibitor in an elderly man].
    Kikuchi M, Sano M, Shimamoto Y, Yamaguchi M, Tadano J, Takahashi I, Kamiya T.
    Rinsho Ketsueki; 1993 Jul; 34(7):876-8. PubMed ID: 7689663
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H.
    Thromb Haemost; 1993 Mar 01; 69(3):240-6. PubMed ID: 7682339
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome.
    Yamamoto K, Niiya K, Shigematu T, Kiguchi T, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Shima M, Harada M.
    Int J Hematol; 2000 Dec 01; 72(4):517-9. PubMed ID: 11197224
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 Dec 01; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 19. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
    Kubota Y, Sano M, Nakazato S, Tsuneyoshi N, Tomimasu R, Kuwahara N, Fukushima N, Funai N, Suga K, Sueoka E.
    Rinsho Ketsueki; 2004 Sep 01; 45(9):1023-7. PubMed ID: 15510829
    [Abstract] [Full Text] [Related]

  • 20. [The antiphospholipid syndrome during chronic lymphatic leukemia. An association with anti-factor VIII antibodies].
    Ghirarduzzi A, Silingardi M, D'Incà M, Tincani E.
    Ann Ital Med Int; 1999 Sep 01; 14(1):46-50. PubMed ID: 10528424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.